Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LEMAITRE VASCULAR INCLMAT · Entity 1927 | Director | September 03, 2026 | September 08, 2026 |
| Lifeward Ltd.LFWD · Entity 7620 | Director · Chief Executive Officer | May 21, 2025 | May 22, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LEMAITRE VASCULAR INC
Report date September 03, 2026 · Filed September 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 5.6103 |
Reported balance
After 2026-09-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-03 · Grant · Acquired 0.5429 · Balance 5.6103 F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 5.5195 |
Reported balance
After 2026-09-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-03 · Grant · Acquired 0.6503 · Balance 5.5195 F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 5.1836 |
Reported balance
After 2026-09-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-09-03 · Grant · Acquired 0.8852 · Balance 5.1836 F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 5.486 |
Reported balance
After 2026-09-03 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-09-03 · Grant · Acquired 1.0022 · Balance 5.486 F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 4.2988 |
Reported balance
After 2026-09-03 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-09-03 · Grant · Acquired 1.6637 · Balance 4.2988 F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
Lifeward Ltd.
Report date May 21, 2025 · Filed May 22, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary Shares, par value NIS 1.75 per shareSEC Table I · non-derivative | IndirectESOP | 98,728 |
Reported balance
After 2025-05-21 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2025-05-21 · Sale · Disposed 1,909 · Balance 98,728 F1: Represents Ordinary Shares sold in the open market on May 21, 2025, in order to satisfy the Reporting Person's tax withholding obligation in connection with the vesting, on May 21, 2025, of certain restricted stock units ("RSUs") previously granted to the Reporting Person under the ReWalk 2014 Equity Incentive Plan on May 21, 2021 (the "Grant Date"). The Ordinary Shares were sold pursuant to an automatic sell-to-cover arrangement between the Reporting Person and Lifeward Ltd. (the "Company") and does not represent a discretionary trade by the Reporting Person. |
| Ordinary Shares, par value NIS 1.75 per shareSEC Table I · non-derivative | Direct | 2,142 |
Reported balance
Holding disclosure · report date 2025-05-21 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 2,142 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents Ordinary Shares sold in the open market on May 21, 2025, in order to satisfy the Reporting Person's tax withholding obligation in connection with the vesting, on May 21, 2025, of certain restricted stock units ("RSUs") previously granted to the Reporting Person under the ReWalk 2014 Equity Incentive Plan on May 21, 2021 (the "Grant Date"). The Ordinary Shares were sold pursuant to an automatic sell-to-cover arrangement between the Reporting Person and Lifeward Ltd. (the "Company") and does not represent a discretionary trade by the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 11, 2023 Filed Dec 13, 2023 22:05 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 2 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-034356 · rdgdoc.xml · derivative · entry 3 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6.4383 Underlying: Common Stock · 2 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 11, 2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 11, 2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 11, 2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 11, 2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 11, 2023 Filed Dec 13, 2023 22:05 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 2 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-034356 · rdgdoc.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,824 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 08, 2023 Filed Dec 12, 2023 22:41 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantStock Option (Right to Buy) · Derivative | 2,772 | $0.00 Strike: $54.65 | $0.00 |
DisclosureSEC source: 0001437749-23-034239 · rdgdoc.xml · derivative · entry 2 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,772 Underlying: Common Stock · 2,772 shares Expires 2028-12-08 F2 · derivative.exercise_date: This option is exercisable and vests over a three-year period at a rate of 33 1/3% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining two years. Read SEC document |
| December 08, 2023 Filed Dec 12, 2023 22:41 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantCommon Stock | 512 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-034239 · rdgdoc.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,822 F1 · shares: Represents a restricted stock unit award that vests on a time-based schedule as follows: 33 1/3% of the award vests on the anniversary of the grant date listed in the table, with the balance vesting in equal annual installments over the remaining two years. Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 21:03 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.5871 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-033500 · rdgdoc.xml · derivative · entry 2 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5.9867 Underlying: Common Stock · 1.5871 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 21:03 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.0385 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-033500 · rdgdoc.xml · derivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8.44 Underlying: Common Stock · 1.0385 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 13, 2023 Filed Sep 19, 2023 20:39 UTC | Lifeward Ltd. RWLK · Entity 7620 | GrantOrdinary Shares, par value NIS 0.25 per share | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-018267 · form4.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · ESOP Disclosed balance after: 751,276 F1 · shares: Represents 200,000 ordinary shares, par value NIS 0.25 per share, issuable upon the vesting of restricted stock units ("RSUs") granted on September 13, 2023 (the "Grant Date") under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The RSUs vest ratably in four equal annual installments, commencing as of the Grant Date. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 19:48 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.4433 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-025191 · rdgdoc.xml · derivative · entry 2 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4.3996 Underlying: Common Stock · 1.4433 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 19:48 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.944 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-025191 · rdgdoc.xml · derivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7.4 Underlying: Common Stock · 0.944 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| August 02, 2023 Filed Aug 5, 2023 00:18 UTC | Lifeward Ltd. RWLK · Entity 7620 | SaleOrdinary Shares, par value NIS 0.25 per share | 15,237 | $0.69 | $10,524.20 |
DisclosureSEC source: 0001062993-23-015885 · form4.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · ESOP Disclosed balance after: 551,276 F1 · shares: Represents Ordinary Shares sold in the open market on August 2, 2023, in order to satisfy the Reporting Person's tax withholding obligation in connection with the vesting, on August 2, 2023, of certain restricted stock units ("RSUs") previously granted to the Reporting Person under the ReWalk 2014 Equity Incentive Plan on August 2, 2022 (the "Grant Date"). The Ordinary Shares were sold pursuant to an automatic sell-to-cover arrangement between the Reporting Person and ReWalk Robotics Ltd. (the "Company") and does not represent a discretionary trade by the Reporting Person. F2 · price: Reflects the weighted average sale price for Ordinary Shares sold. Actual sale prices for the shares sold ranged from $0.68 to $0.7103. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price. Read SEC document |
| June 20, 2023 Filed Jun 21, 2023 21:04 UTC | Lifeward Ltd. RWLK · Entity 7620 | SaleOrdinary Shares, par value NIS 0.25 per share | 22,920 | $0.59 | $13,564.06 |
DisclosureSEC source: 0001062993-23-013928 · form4.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · ESOP Disclosed balance after: 566,513 F1 · shares: Represents Ordinary Shares sold in the open market on June 20, 2023, in order to satisfy the reporting person's tax withholding obligation in connection with the vesting, on June 18, 2023, of certain restricted stock units ("RSUs") previously granted to Mr. Jasinski under the ReWalk 2014 Equity Incentive Plan on June 18, 2020 (the "Grant Date"). The Ordinary Shares were sold pursuant to an automatic sell-to-cover arrangement between Mr. Jasinski and ReWalk Robotics Ltd. (the "Company") and does not represent a discretionary trade by Mr. Jasinski. F2 · price: Reflects the weighted average sale price for Ordinary Shares sold. Actual sale prices for the shares sold ranged from $0.59 to $0.60. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 20:30 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.2968 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-016644 · rdgdoc.xml · derivative · entry 2 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2.9563 Underlying: Common Stock · 1.2968 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 20:30 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.8464 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-016644 · rdgdoc.xml · derivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6.46 Underlying: Common Stock · 0.8464 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 22, 2023 Filed May 24, 2023 20:26 UTC | Lifeward Ltd. RWLK · Entity 7620 | SaleOrdinary Shares, par value NIS 0.25 per share | 11,457 | $0.61 | $6,979.60 |
DisclosureSEC source: 0001062993-23-012044 · form4.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · ESOP Disclosed balance after: 589,433 F1 · shares: Represents Ordinary Shares sold in the open market on May 22, 2023, in order to satisfy the reporting person's tax withholding obligation in connection with the vesting, on May 22, 2023, of certain restricted stock units previously granted to the reporting person under the ReWalk 2014 Equity Incentive Plan. The Ordinary Shares were sold pursuant to an automatic sell-to-cover arrangement between Mr. Jasinski and the Company. F2 · price: Reflects the weighted average sale price for Ordinary Shares sold. Actual sale prices for the shares sold ranged from $0.60 to $0.617. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price. Read SEC document |
| May 09, 2023 Filed May 11, 2023 20:07 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,148 | $0.00 Strike: $48.60 | $0.00 |
DisclosureSEC source: 0001437749-23-013936 · rdgdoc.xml · derivative · entry 5 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,296 Underlying: Common Stock · 1,148 shares Expires 2026-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Represents a stock option award that vests on a time-based schedule as follows: 33 1/3% of the award vests on the anniversary of the grant date listed in the table, with the balance besting in equal annual installments over the remaining two years. Read SEC document |
| May 09, 2023 Filed May 11, 2023 20:07 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $35.48 | $0.00 |
DisclosureSEC source: 0001437749-23-013936 · rdgdoc.xml · derivative · entry 4 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires 2024-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| May 09, 2023 Filed May 11, 2023 20:07 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 3,648 | $66.00 | $240,768.00 |
DisclosureSEC source: 0001437749-23-013936 · rdgdoc.xml · nonDerivative · entry 3 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,310 Read SEC document |
| May 09, 2023 Filed May 11, 2023 20:07 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 1,148 | $48.60 | $55,792.80 |
DisclosureSEC source: 0001437749-23-013936 · rdgdoc.xml · nonDerivative · entry 2 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,958 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| May 09, 2023 Filed May 11, 2023 20:07 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 2,500 | $35.48 | $88,700.00 |
DisclosureSEC source: 0001437749-23-013936 · rdgdoc.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,810 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| March 27, 2023 Filed Apr 3, 2023 20:11 UTC | Lifeward Ltd. RWLK · Entity 7620 | Tax withholdingOrdinary Shares, par value NIS 0.25 per share | 196 | $0.66 | $129.36 |
DisclosureSEC source: 0001062993-23-008294 · form4.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · ESOP Disclosed balance after: 600,890 F1 · date: This Form 4 is being filed late due to an administrative error. F2 · shares: Represents Ordinary Shares sold in the open market on March 27, 2023, in order to satisfy the reporting person's tax withholding obligation in connection with the vesting, on March 27, 2023, of certain restricted stock units previously granted to the reporting person under the ReWalk 2014 Equity Incentive Plan. The Ordinary Shares were sold pursuant to an automatic sell-to-cover arrangement between Mr. Jasinski and the Company. F3 · price: Sale price per share of the Company's Ordinary Shares on the transaction date. Read SEC document |
| March 23, 2023 Filed Mar 27, 2023 12:23 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.6595 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-007964 · rdgdoc.xml · derivative · entry 2 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1.6595 Underlying: Common Stock · 1.6595 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 23, 2023 Filed Mar 27, 2023 12:23 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.083 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-007964 · rdgdoc.xml · derivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5.6094 Underlying: Common Stock · 1.083 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 15, 2023 Filed Mar 16, 2023 20:06 UTC | Lifeward Ltd. RWLK · Entity 7620 | PurchaseOrdinary Shares, par value NIS 0.25 per share | 15,000 | $0.72 | $10,810.50 |
DisclosureSEC source: 0001062993-23-007023 · form4.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 F1 · price: Reflects the weighted average sale price for Ordinary Shares purchased. Actual purchase prices for the shares purchased ranged from $0.69 to $0.75. The Reporting Person undertakes to provide ReWalk Robotics Ltd. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission full information regarding the number of shares purchased at each separate price. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:03 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 192 | $50.00 | $9,600.00 |
DisclosureSEC source: 0001437749-23-005525 · rdgdoc.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,310 Read SEC document |
| December 12, 2022 Filed Dec 13, 2022 22:33 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantStock Option (Right to Buy) · Derivative | 3,209 | $0.00 Strike: $47.19 | $0.00 |
DisclosureSEC source: 0001437749-22-029005 · rdgdoc.xml · derivative · entry 2 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,209 Underlying: Common Stock · 3,209 shares Expires 2027-12-12 F2 · derivative.exercise_date: This option is exercisable and vests over a three-year period at a rate of 33 1/3% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining two years. Read SEC document |
| December 12, 2022 Filed Dec 13, 2022 22:33 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantCommon Stock | 593 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-029005 · rdgdoc.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,502 F1 · shares: Represents a restricted stock unit award that vests on a time-based schedule as follows: 33 1/3% of the award vests on the anniversary of the grant date listed in the table, with the balance vesting in equal annual installments over the remaining two years. Read SEC document |
| December 02, 2022 Filed Dec 6, 2022 01:06 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $37.29 | $0.00 |
DisclosureSEC source: 0001437749-22-028468 · rdgdoc.xml · derivative · entry 8 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 5,000 shares Expires 2025-12-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option is exercisable and vests over a three-year period at a rate of 33 1/3% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining two years. Read SEC document |
| December 02, 2022 Filed Dec 6, 2022 01:06 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $35.48 | $0.00 |
DisclosureSEC source: 0001437749-22-028468 · rdgdoc.xml · derivative · entry 7 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2024-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option is exercisable and vests over a three-year period at a rate of 33 1/3% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining two years. Read SEC document |
| December 02, 2022 Filed Dec 6, 2022 01:06 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $23.56 | $0.00 |
DisclosureSEC source: 0001437749-22-028468 · rdgdoc.xml · derivative · entry 6 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires 2023-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| December 02, 2022 Filed Dec 6, 2022 01:06 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 10,000 | $47.07 | $470,697.00 |
DisclosureSEC source: 0001437749-22-028468 · rdgdoc.xml · nonDerivative · entry 4 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,909 F2 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $47.00 to $47.23. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| December 02, 2022 Filed Dec 6, 2022 01:06 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 5,000 | $37.29 | $186,450.00 |
DisclosureSEC source: 0001437749-22-028468 · rdgdoc.xml · nonDerivative · entry 3 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,909 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| December 02, 2022 Filed Dec 6, 2022 01:06 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 2,500 | $35.48 | $88,700.00 |
DisclosureSEC source: 0001437749-22-028468 · rdgdoc.xml · nonDerivative · entry 2 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,909 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| December 02, 2022 Filed Dec 6, 2022 01:06 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 2,500 | $23.56 | $58,900.00 |
DisclosureSEC source: 0001437749-22-028468 · rdgdoc.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,409 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| December 01, 2022 Filed Dec 6, 2022 01:06 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.5264 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-028468 · rdgdoc.xml · derivative · entry 5 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4.5264 Underlying: Common Stock · 1.5264 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 08, 2022 Filed Sep 12, 2022 20:52 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-022216 · rdgdoc.xml · derivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3 Underlying: Common Stock · 1 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| August 02, 2022 Filed Aug 3, 2022 20:04 UTC | Lifeward Ltd. RWLK · Entity 7620 | GrantOrdinary Shares, par value NIS 0.25 per share | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-017161 · form4.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 601,086 F1 · shares: Represents 200,000 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on August 2, 2022 under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The RSUs vest ratably in four equal annual installments, commencing as of August 2, 2022. Read SEC document |
| June 18, 2022 Filed Jul 7, 2022 20:03 UTC | Lifeward Ltd. RWLK · Entity 7620 | Tax withholdingOrdinary Shares, par value NIS 0.25 per share | 22,797 | $0.87 | $19,833.39 |
DisclosureSEC source: 0001062993-22-016136 · form4.xml · nonDerivative · entry 4 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 401,086 F2 · shares: Represents ordinary shares sold in the open market on each of the respective transaction dates, in order to satisfy the reporting person's tax withholding obligation in connection with the vesting, on each of the transaction dates, of certain restricted stock units ("RSUs") previously granted to the reporting person under the ReWalk 2014 Equity Incentive Plan. The ordinary shares were sold pursuant to an automatic sell-to-cover arrangement between Mr. Jasinski and the Company. F3 · price: Sale price per share of the Company's ordinary shares on the transaction date. F4 · balance_after: Due to an administrative oversight, on October 6, 2020, the reporting person incorrectly reported the disposition of 348 ordinary shares sold in the open market in order to satisfy the reporting person's tax withholding obligation in connection with the vesting of certain RSUs, rather than the 324 ordinary shares actually sold by the reporting person. The amounts reported in this Form 4 reflect the reporting person's corrected ownership. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 20:31 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-014410 · rdgdoc.xml · derivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2 Underlying: Common Stock · 1 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 21, 2022 Filed Jul 7, 2022 20:03 UTC | Lifeward Ltd. RWLK · Entity 7620 | Tax withholdingOrdinary Shares, par value NIS 0.25 per share | 11,400 | $0.88 | $10,032.00 |
DisclosureSEC source: 0001062993-22-016136 · form4.xml · nonDerivative · entry 3 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 423,883 F2 · shares: Represents ordinary shares sold in the open market on each of the respective transaction dates, in order to satisfy the reporting person's tax withholding obligation in connection with the vesting, on each of the transaction dates, of certain restricted stock units ("RSUs") previously granted to the reporting person under the ReWalk 2014 Equity Incentive Plan. The ordinary shares were sold pursuant to an automatic sell-to-cover arrangement between Mr. Jasinski and the Company. F3 · price: Sale price per share of the Company's ordinary shares on the transaction date. Read SEC document |
| March 27, 2022 Filed Jul 7, 2022 20:03 UTC | Lifeward Ltd. RWLK · Entity 7620 | Tax withholdingOrdinary Shares, par value NIS 0.25 per share | 220 | $1.13 | $248.60 |
DisclosureSEC source: 0001062993-22-016136 · form4.xml · nonDerivative · entry 2 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 435,283 F2 · shares: Represents ordinary shares sold in the open market on each of the respective transaction dates, in order to satisfy the reporting person's tax withholding obligation in connection with the vesting, on each of the transaction dates, of certain restricted stock units ("RSUs") previously granted to the reporting person under the ReWalk 2014 Equity Incentive Plan. The ordinary shares were sold pursuant to an automatic sell-to-cover arrangement between Mr. Jasinski and the Company. F3 · price: Sale price per share of the Company's ordinary shares on the transaction date. Read SEC document |
| March 24, 2022 Filed Mar 29, 2022 01:08 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-007477 · rdgdoc.xml · derivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1 Underlying: Common Stock · 1 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 11, 2021 Filed Dec 14, 2021 21:19 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantStock Option (Right to Buy) · Derivative | 3,444 | $0.00 Strike: $48.60 | $0.00 |
DisclosureSEC source: 0001437749-21-028557 · rdgdoc.xml · derivative · entry 2 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,444 Underlying: Common Stock · 3,444 shares Expires 2026-12-11 F2 · derivative.exercise_date: This option is exercisable and vests over a three-year period at a rate of 33 1/3% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining two years. Read SEC document |
| December 11, 2021 Filed Dec 14, 2021 21:19 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantCommon Stock | 576 | $48.60 | $27,993.60 |
DisclosureSEC source: 0001437749-21-028557 · rdgdoc.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,909 F1 · shares: Represents a restricted stock unit award that vests on a time-based schedule as follows: 33 1/3% of the award vests on the anniversary of the grant date listed in the table, with the balance vesting in equal annual installments over the remaining two years. This award includes a provision for the withholding of shares by the Issuer to pay the withholding taxes due on each vesting date. Read SEC document |
| July 01, 2021 Filed Jul 7, 2022 20:03 UTC | Lifeward Ltd. RWLK · Entity 7620 | Tax withholdingOrdinary Shares, par value NIS 0.25 per share | 87 | $1.57 | $136.59 |
DisclosureSEC source: 0001062993-22-016136 · form4.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 435,503 F1 · date: This Form 4 is being filed late due to an administrative error. F2 · shares: Represents ordinary shares sold in the open market on each of the respective transaction dates, in order to satisfy the reporting person's tax withholding obligation in connection with the vesting, on each of the transaction dates, of certain restricted stock units ("RSUs") previously granted to the reporting person under the ReWalk 2014 Equity Incentive Plan. The ordinary shares were sold pursuant to an automatic sell-to-cover arrangement between Mr. Jasinski and the Company. F3 · price: Sale price per share of the Company's ordinary shares on the transaction date. Read SEC document |
| June 21, 2021 Filed Jun 21, 2021 20:31 UTC | Lifeward Ltd. RWLK · Entity 7620 | SaleOrdinary Shares, par value NIS 0.25 per share | 22,500 | $1.69 | $38,025.00 |
DisclosureSEC source: 0001178913-21-002116 · zk2126211.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 435,566 F1 · shares: Represents Ordinary Shares sold in the open market on June 21, 2021, in order to satisfy the reporting person's tax withholding obligation in connection with the vesting, on June 18, 2021, of certain restricted stock units ("RSUs") previously granted to the reporting person under the ReWalk 2014 Equity Incentive Plan. The Ordinary Shares were sold pursuant to an automatic sell-to-cover arrangement between Mr. Jasinski and the Company. F2 · price: Sale price per share of the Company's Ordinary Shares on the transaction date. Read SEC document |
| May 21, 2021 Filed May 25, 2021 10:02 UTC | Lifeward Ltd. RWLK · Entity 7620 | GrantOrdinary Shares, par value NIS 0.25 per share | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-21-001862 · zk2126078.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 458,066 F1 · shares: Represents 150,000 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on May 21, 2021 under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The RSUs vest ratably in four equal annual installments starting on the first anniversary of the grant date. Read SEC document |
| May 04, 2021 Filed May 5, 2021 20:46 UTC | Lifeward Ltd. RWLK · Entity 7620 | SaleOrdinary Shares, par value NIS 0.25 per share | 148 | $1.90 | $281.20 |
DisclosureSEC source: 0001178913-21-001613 · zk2125986.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 308,066 F1 · shares: Represents Ordinary Shares sold in the open market on May 4, 2021, in order to satisfy the reporting person's tax withholding obligation in connection with the vesting, on May 3, 2021, of certain restricted stock units ("RSUs") previously granted to the reporting person under the ReWalk 2014 Equity Incentive Plan. The Ordinary Shares were sold pursuant to an automatic sell-to-cover arrangement between Mr. Jasinski and the Company. F2 · price: Sale price per share of the Company's Ordinary Shares on the transaction date. Read SEC document |
| March 29, 2021 Filed Mar 29, 2021 20:00 UTC | Lifeward Ltd. RWLK · Entity 7620 | Tax withholdingOrdinary Shares, par value NIS 0.25 per share | 202 | $2.38 | $480.76 |
DisclosureSEC source: 0001178913-21-001214 · zk2125825.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 308,214 F1 · shares: Represents Ordinary Shares sold in the open market on March 29, 2021, in order to satisfy the reporting person's tax withholding obligation in connection with the vesting, on March 27, 2021, of certain restricted stock units ("RSUs") previously granted to the reporting person under the ReWalk 2014 Equity Incentive Plan. F2 · price: Market price per share of the Company's Ordinary Shares on the transaction date. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 01:29 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $35.48 | $0.00 |
DisclosureSEC source: 0001437749-21-004907 · rdgdoc.xml · derivative · entry 7 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 2,500 shares Expires 2024-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is exercisable and vests over a three-year period at a rate of 33 1/3% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining two years. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 01:29 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $23.56 | $0.00 |
DisclosureSEC source: 0001437749-21-004907 · rdgdoc.xml · derivative · entry 6 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2023-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is exercisable and vests over a three-year period at a rate of 33 1/3% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining two years. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.